1-9 of 9
N. Vey
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Lenalidomide (LEN) in INT 2 and High Risk MDS with DEL 5q. Interim Results of a Phase II Trial by the GFM.

S. Burcheri, MD, T. Prebet, MD, O. Beyne-Rauzy, MD, R.M. Mbida, MD, N. Hoarau, MD, L. Legros, MD, C. Ravoet, MD, F. Dreyfus, MD, A. Stamatoullas, MD, M.P. Chaury, MD, J. Delaunay, MD, G. Laurent, MD, N. Vey, MD, L. Ades, MD, C. Gardin, MD, Pierre Fenaux, MD
Journal: Blood
Blood (2007) 110 (11): 820.
https://doi.org/10.1182/blood.V110.11.820.820
Published: 2007
Journal Articles

Prognostic Factors and Response Duration in 419 MDS Treated with Erythropoietin±GCSF: The GFM Experience.

S. Park, C. Kelaidi, S. Grabar, O. Beyne-Rauzy, S. Cheze, V. Bardet, M. Escoffre-Barbe, C. Ravoet, A. Ferrant, N. Vey, H. Dombret, B. Mahe, L. Mannone, L. Legros, L. Aljassem, A. Stamatoullas, D. Vassilief, M.C. Quarre, L. Ades, V. Andrieux, S. Giraudier, S. de Botton, N. Casadevall, P. Fenaux, F. Dreyfus
Journal: Blood
Blood (2006) 108 (11): 522.
https://doi.org/10.1182/blood.V108.11.522.522
Published: 2006
Journal Articles

Sustained Effect of First Line Sequential Therapy with Intensive Consolidation Chemotherapy and Allogeneic Hematopoietic Stem Cell Transplantation (ASCT) after Reduced Intensity Conditioning (RIC) for Patients with Acute Myeloblastic Leukemia (AML) in First Complete Remission (CR1).

Didier Blaise, MD, R. Tabrizi, MD, C. Faucher, MD, Mohamad Mohty, MD, J.O. Bay, MD, J.M. Boiron, MD, G. Marit, MD, S. Furst, MD, A.M. Stoppa, MD, A. Charbonnier, MD, T. Prebet, MD, C. Chabannon, MD, N. Vey
Journal: Blood
Blood (2006) 108 (11): 3000.
https://doi.org/10.1182/blood.V108.11.3000.3000
Published: 2006
Journal Articles

No Benefit of Adding High-Dose Melphalan (HDM) Suppported by Autologous Stem Cell Transplantation (SCT) over Treatment with Conventional Induction, HD ARAC Consolidation, and Auto SCT (Busulfan + HDM) for Acute Myelogenous Leukemia (AML) under 60: First Results of the Randomized AML 2001 Trial.

B. Lioure, A. Pigneux, C. Recher, F. Witz, T. Lamy, N. Fegueux, C.E. Bulabois, N. Ifrah, I. Luquet, D. Bouscary, N. Vey, M. Delain, J.O. Bay, P. Turlure, Jean-Luc Harousseau
Journal: Blood
Blood (2006) 108 (11): 608.
https://doi.org/10.1182/blood.V108.11.608.608
Published: 2006
Journal Articles

Is There a Role for ATRA in Combination to EPO in Lower Risk Myelodysplastic Syndrome? Preliminary Results of a Phase II Study.

L. Ades, H. Mohamed, D. Vassilief, E. Berger, B. Slama, N. Vey, R. Delarue, O. Beyne-Rauzy, A. Guerci, S. Cheze, X. Thomas, A. Stamatoullas, M. Gardembas, F. Bauduer, A. Kolb, M.C. Chaury, L. Legros, G. Damaj, F. Hamza, S. Vaultier, F. Dreyfus, P. Fenaux
Journal: Blood
Blood (2005) 106 (11): 2537.
https://doi.org/10.1182/blood.V106.11.2537.2537
Published: 2005
Journal Articles

Stem Cell Transplantation in 281 Patients over 60 Years in Onco Hematologic Malignancies: A Single Center Experience.

Anne-Marie Stoppa, MD, N. Vey, MD, C. Faucher, MD, R. Bouabdallah, MD, F. Viret, MD, C. Chabannon, MDPhD, P. Ladaique, MD, D. Coso, MD, A. Charbonnier, MDPhD, J.M. Schiano, MD, P. Viens, MD, J.A. Gastaut, MD, D. Maraninchi, MD, D. Blaise, MD
Journal: Blood
Blood (2004) 104 (11): 5229.
https://doi.org/10.1182/blood.V104.11.5229.5229
Published: 2004
Journal Articles

First Line Therapy with Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation for Patients with Acute Myeloblastic Leukemia in First Complete Remission.

Didier Blaise, J.M. Boiron, C. Faucher, M. Mohty, J.O. Bay, K. Bilger, G. Marit, V.J. Bardoux, V. Perreau, D. Coso, A.M. Stoppa, J.A. Gastaut, J. Reiffers, D. Maraninchi, N. Vey
Journal: Blood
Blood (2004) 104 (11): 101.
https://doi.org/10.1182/blood.V104.11.101.101
Published: 2004
Journal Articles

Long Term Infectious Complications Following Reduced Intensity Conditioning (RIC)Allogeneic HLA-Identical Sibling Transplantation (allo-SCT).

A. Etienne, M. Mohty, C. Faucher, M. Ferrando, R. Benramdane, C. Zandotti, L. Collet, N. Vey, A.M. Stoppa, D. Coso, P. Viens, J.A. Gastaut, D. Blaise
Journal: Blood
Blood (2004) 104 (11): 1234.
https://doi.org/10.1182/blood.V104.11.1234.1234
Published: 2004
Journal Articles

Fludarabine and Busulfan-Based Reduced Intensity Conditioning (RIC) Allogeneic HLA-Identical Transplantation (allo-SCT) with or without Anti-Thymocyte Globulin (ATG): Comparison between Two Prospective Studies in Patients with Myeloid Malignancies.

Mohamad Mohty, R. Martino, C. Faucher, J.A. Perez-Simon, N. Vey, M.D. Caballero, J.A. Gastaut, J. San Miguel, D. Blaise, J. Sierra
Journal: Blood
Blood (2004) 104 (11): 1241.
https://doi.org/10.1182/blood.V104.11.1241.1241
Published: 2004